NCT04630496

Brief Summary

This study is examining collecting data on steps walked (ambulation) per day by thoracic surgery patients over the age of 65 years-old before surgery. The name(s) of the study device involved in this study is:

  • Fitbit inspire

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 13, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 16, 2020

Completed
9 months until next milestone

Study Start

First participant enrolled

August 25, 2021

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

April 13, 2025

Status Verified

April 1, 2025

Enrollment Period

4.3 years

First QC Date

November 13, 2020

Last Update Submit

April 9, 2025

Conditions

Keywords

Thoracic DiseasesLung ResectionPerioperative activityPedometer tracker

Outcome Measures

Primary Outcomes (4)

  • Step Tracking Rate

    Feasibility will be determined by the successful tracking of steps and keeping a diary of step-count for one-week duration. Completion of a minimum of 5/7 days will be considered as a success

    1 week

  • Diary of Steps Rate

    Feasibility will be determined by the successful tracking of steps and keeping a diary of step-count for one-week duration. We will consider completion of a minimum of 5/7 days as a success.

    1 week

  • Return Rate

    If 90% of trackers are returned, it will be considered a successful return.

    1 week

  • Data Retrieval Rate

    assess extraction of the data from the mobility upon return. Success will be considered if 90% of data is retrievable

    1 week

Study Arms (1)

PRE-OPERATIVE EXERCISE TRACKING

EXPERIMENTAL

Participant baseline information will be collected from their electronic medical records. After enrollment, participants will be provided a mobile device (Fitbit) to wear for tracking steps for 1 week prior to their scheduled surgery. Participants will keep a log of daily steps for the 1 week they are wearing the device and receive one progress check-in call during the week. The device and log will be turned in either on a pre-surgery clinic visit or on the day of surgery whichever comes first.

Behavioral: Fitbit

Interventions

FitbitBEHAVIORAL

Electronic activity tracker

Also known as: mobility tracker, pedometer
PRE-OPERATIVE EXERCISE TRACKING

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patients Aged ≥ 65 years
  • Who are preparing to undergo thoracic surgery at Brigham and Women's Hospital (BWH)

You may not qualify if:

  • Patients who are completely non-ambulatory (i.e. wheelchair-bound-patients) \*
  • Those who lack capacity to consent due to cognitive disease.
  • Patient for which surgery is felt to be more urgent and therefore performed earlier then our required timeframe for intervention.
  • Patients with cardiac disease or angina for which formal cardiac testing is required for clearance.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

RECRUITING

Dana-Farber Cancer Institute

Boston, Massachusetts, 02215, United States

RECRUITING

MeSH Terms

Conditions

Thoracic DiseasesMotor Activity

Condition Hierarchy (Ancestors)

Respiratory Tract DiseasesBehavior

Study Officials

  • Michael T Jaklitsch, MD

    Brigham and Women's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Michael T Jaklitsch, MD

CONTACT

Anupama Singh, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 13, 2020

First Posted

November 16, 2020

Study Start

August 25, 2021

Primary Completion

December 1, 2025

Study Completion

January 1, 2026

Last Updated

April 13, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

The Dana-Farber / Harvard Cancer Center encourages and supports the responsible and ethical sharing of data from clinical trials. De-identified participant data from the final research dataset used in the published manuscript may only be shared under the terms of a Data Use Agreement. Requests may be directed to: \[contact information for Sponsor Investigator or designee\]. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Data can be shared no earlier than 1 year following the date of publication
Access Criteria
Contact the Partners Innovations team at http://www.partners.org/innovation

Locations